Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 2
2006 1
2008 1
2009 7
2010 1
2011 3
2012 2
2013 2
2014 2
2015 1
2016 5
2017 6
2018 3
2019 4
2020 6
2021 7
2022 10
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators. Mok TS, et al. N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6. N Engl J Med. 2017. PMID: 27959700 Free PMC article. Clinical Trial.
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer.
Pinato DJ, Howlett S, Ottaviani D, Urus H, Patel A, Mineo T, Brock C, Power D, Hatcher O, Falconer A, Ingle M, Brown A, Gujral D, Partridge S, Sarwar N, Gonzalez M, Bendle M, Lewanski C, Newsom-Davis T, Allara E, Bower M. Pinato DJ, et al. Among authors: newsom davis t. JAMA Oncol. 2019 Dec 1;5(12):1774-1778. doi: 10.1001/jamaoncol.2019.2785. JAMA Oncol. 2019. PMID: 31513236 Free PMC article.
HIV-associated anal cancer.
Newsom-Davis T, Bower M. Newsom-Davis T, et al. F1000 Med Rep. 2010 Dec 8;2:85. doi: 10.3410/M2-85. F1000 Med Rep. 2010. PMID: 21283597 Free PMC article.
The promiscuous receptor.
Newsom-Davis TE, Kenny LM, Ngan S, King J, Waxman J. Newsom-Davis TE, et al. BJU Int. 2009 Nov;104(9):1204-7. doi: 10.1111/j.1464-410X.2009.08599.x. Epub 2009 Apr 24. BJU Int. 2009. PMID: 19426197
Novel cancer therapies: treatments driven by tumour biology.
Ramaswami R, Harding V, Newsom-Davis T. Ramaswami R, et al. Among authors: newsom davis t. Postgrad Med J. 2013 Nov;89(1057):652-8. doi: 10.1136/postgradmedj-2012-131533. Postgrad Med J. 2013. PMID: 24129032 Review.
COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary.
Round T, L'Esperance V, Bayly J, Brain K, Dallas L, Edwards JG, Haswell T, Hiley C, Lovell N, McAdam J, McCutchan G, Nair A, Newsom-Davis T, Sage EK, Navani N. Round T, et al. Among authors: newsom davis t. Br J Cancer. 2021 Aug;125(5):629-640. doi: 10.1038/s41416-021-01361-6. Epub 2021 May 10. Br J Cancer. 2021. PMID: 33972746 Free PMC article. Review.
Is TRAIL the holy grail of cancer therapy?
Newsom-Davis T, Prieske S, Walczak H. Newsom-Davis T, et al. Apoptosis. 2009 Apr;14(4):607-23. doi: 10.1007/s10495-009-0321-2. Apoptosis. 2009. PMID: 19194800 Review.
Immunotherapy for HIV-associated non-Hodgkin's lymphoma.
Newsom-Davis T, Ahamed E, Bower M. Newsom-Davis T, et al. Expert Opin Biol Ther. 2009 Oct;9(10):1313-24. doi: 10.1517/14712590903183516. Expert Opin Biol Ther. 2009. PMID: 19645631 Review.
68 results